FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.07-9718com.
(The FASEB Journal. 2008;22:1104-1112.)
© 2008 FASEB
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
fj.07-9718comv1
22/4/1104    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Qiu, Y.
Right arrow Articles by Harper, S. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Qiu, Y.
Right arrow Articles by Harper, S. J.
(The FASEB Journal. 2008;22:1104-1112.)
© 2008 FASEB

Mammary alveolar development during lactation is inhibited by the endogenous antiangiogenic growth factor isoform, VEGF165b

Yan Qiu*, Heather Bevan*, Sudath Weeraperuma*, Daniel Wratting*, David Murphy{dagger}, Christopher R Neal*, David O. Bates*,1 and Steven J. Harper*,1

* Microvascular Research Laboratories, School of Veterinary Sciences, and

{dagger} Henry Wellcome Laboratories for Integrative Neuroscience and Endocrinology, University of Bristol, Bristol, UK

1Correspondence: Microvascular Research Laboratories, Department of Physiology, Preclinical Veterinary School, University of Bristol, Southwell St., Bristol BS2 8EJ, UK. E-mail: D.O.B, dave.bates{at}bris.ac.uk; S.J.H., s.harper{at}bris.ac.uk

Extensive tissue remodeling occurs in breast tissue during pregnancy, resulting in growth and development of the mammary gland associated with extensive vascular remodeling, which is thought to be dependent on vascular endothelial growth factor (VEGF). We show here that the endogenous antiangiogenic splice isoform of VEGF, VEGF165b, is normally expressed in nonlactating human and mouse breast, and is down-regulated in WT mice during lactation. To demonstrate the physiological role of VEGF165b in mammary tissue, we generated transgenic (TG) mice expressing VEGF165b, under the control of the mouse mammary tumor virus (MMTV) enhancer/promoter. These mice increase expression of VEGF165b in mammary tissue during mammary development. The offspring of TG mothers, but not TG fathers, die shortly after birth. The female TG mice have fewer blood vessels, less blood in the mammary tissue, and impaired alveolar coverage of the fat pad, and do not produce sufficient milk for nourishment of their pups. These findings demonstrate that endogenous overexpression of VEGF165b in the mammary gland inhibits physiological angiogenesis and that the regulation of the balance of VEGF isoforms is a requirement for mammary alveolar development and milk production. This study provides the first evidence for the role of endogenous antiangiogenic VEGF isoforms in normal physiology— their down-regulation is required for effective milk production.—Qiu, Y, Bevan, H., Weeraperuma, S., Wratting, D., Murphy, D., Neal, C. R., Bates, D. O., Harper, S. J. Mammary alveolar development during lactation is inhibited by the endogenous antiangiogenic growth factor isoform, VEGF165b.


Key Words: angiogenesis • splicing • transgenic







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by The Federation of American Societies for Experimental Biology.